1. |
Makita H, Nasuhara Y, Nagai K, et al. Characterization of phenotypes based on severity of emphysema in chronic obstruction pulmonary disease[J]. Thorax, 2007, 62(11): 932-937.
|
2. |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志, 2007, 30(1): 8-17..
|
3. |
Celli BR, Roger S. Mitchell lecture. Chronic obstructive pulmonary disease phenotype and their clinic relevance[J]. Proc Am Thorac Soc, 2006, 3(6): 461-465..
|
4. |
Matsuoka S, Yamashiro T, Washko GR, et al. Quantitative CT assessment of chronic obstructive pulmonary disease[J]. Radiographics, 2010, 30(1): 55-66..
|
5. |
Tatsumi K, Kasahana Y, Kurosu K,et al. Clinical phenotypes of COPD:resulys of a Japanses epidemioligie survey[J]. Respiralogy, 2004, 9(3): 331-336.
|
6. |
程艳慧, 何东初. COPD发病机制分子生物学的最新研究进展[J]. 临床肺科杂志, 2010, 15(2): 232-233.
|
7. |
Fujimoto K, Kitaguchi Y, Kubo K, et al. Clinical analysis of chronicobstructive pulmonary disease phenotypes classified using highresolution computed tomography[J].Respirology, 2006, 11(6): 731-740..
|
8. |
Nakono Y, Muro S, Sakai H, et al. Computed tomographic measurement of airway dimenstions and emphysema in smokers:correlation with lung function[J].Am J Respir Crit Care Med, 2000, 162(3 Pt 1): 1102-1108..
|
9. |
Casaburi R, Kukafka D, Cooper CB, et al. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD[J]. Chest, 2005, 127(3): 809-817..
|
10. |
Barnes PJ, Stockley RA. COPD: current therapeutic interventions and future approaches[J]. Eur Respir, 2005, 25(6): 1084-1106..
|
11. |
Casaburi R, Mahler DA, Jones PW, et al. A Long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease[J].Eur Respir J, 2002, 19(2): 217-224..
|
12. |
Tashkin DP, Celli B, Senn S, et al. A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease[J]. N Engl J Med, 2008, 359(15): 1543-1554..
|
13. |
王长征.药物治疗能改变慢性阻塞性肺疾病患者肺功能的下降速率吗? [J]. 中国呼吸与危重监护杂志, 2009, 8(1): l-2..
|
14. |
Saito Y, Azuma A, Morimoto T, et al. Tiotropium ameliorates symptoms in patients with chronic airway mucus hypersecretion which is resistant to Macrolide therapy[J]. Intern Med, 2008, 47(7): 585-591..
|
15. |
Profita M, Bonanno A, Siena L, et al. Acetylcholine mediates the release of IL-8 in human bronchial cells by a NFκB/ERK-dependent mechanism[J]. Eur J Pharmacol, 2008, 582(1-3): 145-l53..
|
16. |
Bühling F, Lieder N, Kuhlmann UC, et al. Tiotropium suppresses acetylcholine-induced release of chemotactic mediators in vitro[J]. Respir Med, 2007, l01(11): 2386-2394..
|